{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:49:30Z","timestamp":1779889770202,"version":"3.53.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic inflammatory myopathies (IIM) are a diverse group of muscle diseases often complicated by interstitial lung disease (ILD), which significantly impacts morbidity and mortality. Krebs von den Lungen-6 (sKL-6) has been proposed as a biomarker for ILD severity. Nailfold videocapillaroscopy (NVC) detects microvascular changes, but its diagnostic and prognostic value in IIM remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the relationship between NVC abnormalities, sKL-6 levels and pulmonary outcomes in IIM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted in IIM patients from a reference centre, comparing those with and without ILD. Data included epidemiological, clinical and immunological features, pulmonary function tests, sKL-6 levels and NVC findings. Statistical analyses included Spearman\u2019s rank correlation coefficient to assess the relationships between sKL-6 levels, pulmonary function tests and NVC parameters. Multiple logistic regression modelling to identify to identify predictors of IIM-ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 95 patients (34% male, median age 55.3\u2009\u00b1\u200924\u2009years, disease duration 6.8\u2009\u00b1\u20097\u2009years), ILD was associated with avascular zones (P\u2009=\u20090.004), capillary loss (P\u2009=\u20090.04) and microhaemorrhages (P\u2009=\u20090.04). Negative correlations were observed between capillary loss and enlarged capillaries with forced vital capacity (%FVC) (rs\u2009=\u2009\u20130.46, P\u2009=\u20090.001; rs\u2009=\u2009\u20130.57, P\u2009&amp;lt;\u20090.0001) and diffusing capacity of the lungs for carbon monoxide (%DLCO) (rs\u2009=\u2009\u20130.32, P\u2009=\u20090.04; rs\u2009=\u2009\u20130.23, P\u2009=\u20090.03). sKL-6 levels correlated positively with ILD (rs\u2009=\u20090.77, P\u2009=\u20090.0004), microhaemorrhages (rs\u2009=\u20090.21, P\u2009=\u20090.04) and avascular areas (rs\u2009=\u20090.64, P\u2009=\u20090.03), and negatively with %FVC (rs\u2009=\u2009\u20130.47, P\u2009=\u20090.001) and %DLCO (rs\u2009=\u2009\u20130.59, P\u2009=\u20090.005). Predictors of ILD included male sex, respiratory symptoms, %FVC, %DLCO, sKL-6, anti-Jo1 positivity and NVC abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NVC findings, sKL-6 levels, and autoantibodies are valuable in identifying and monitoring ILD in IIM, highlighting their role in early diagnosis and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae669","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:29:51Z","timestamp":1733758191000},"page":"SI88-SI96","source":"Crossref","is-referenced-by-count":4,"title":["Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies\u2013related interstitial lung disease"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-9877","authenticated-orcid":false,"given":"Cristiana","family":"Sieiro Santos","sequence":"first","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]},{"name":"Rheumatology, Complejo Asistencial Universitario de Le\u00f3n , Le\u00f3n,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Tandaipan","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Castillo","sequence":"additional","affiliation":[{"name":"Pulmonology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Codes-Mendez","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-158X","authenticated-orcid":false,"given":"Laura","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Immunology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Magallares","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-5420","authenticated-orcid":false,"given":"Patricia","family":"Moya-Alvarado","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Mariscal","sequence":"additional","affiliation":[{"name":"Immunology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sang","family":"Park","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"D\u00edaz-Torn\u00e9","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana P","family":"Fernandez-Sanchez","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bernardez","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-6787","authenticated-orcid":false,"given":"Hector","family":"Corominas","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Diez Alvarez","sequence":"additional","affiliation":[{"name":"Rheumatology, Complejo Asistencial Universitario de Le\u00f3n , Le\u00f3n,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5410-5807","authenticated-orcid":false,"given":"Ivan","family":"Castellv\u00ed","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2025121017320337200_keae669-B1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2025121017320337200_keae669-B2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2025121017320337200_keae669-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025121017320337200_keae669-B4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fmed.2019.00326","article-title":"Inflammatory myopathy-related interstitial lung disease: from pathophysiology to treatment","volume":"6","author":"Hervier","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2025121017320337200_keae669-B5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"2025121017320337200_keae669-B6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11926-018-0731-7","article-title":"Management of interstitial lung disease in patients with myositis specific autoantibodies","volume":"20","author":"Mecoli","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2025121017320337200_keae669-B7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","article-title":"Assessing microvascular changes in systemic sclerosis diagnosis and management","volume":"6","author":"Cutolo","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2025121017320337200_keae669-B8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025121017320337200_keae669-B9","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3899\/jrheum.130528","article-title":"Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis","volume":"40","author":"Smith","year":"2013","journal-title":"J Rheumatol"},{"key":"2025121017320337200_keae669-B10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3899\/jrheum.121089","article-title":"Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis","volume":"40","author":"Sulli","year":"2013","journal-title":"J Rheumatol"},{"key":"2025121017320337200_keae669-B11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/art.33463","article-title":"Timing of transition between capillaroscopic patterns in systemic sclerosis","volume":"64","author":"Sulli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025121017320337200_keae669-B12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.semarthrit.2008.09.003","article-title":"Nailfold capillary microscopy in adults with inflammatory myopathy","volume":"39","author":"Selva-O\u2019Callaghan","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"2025121017320337200_keae669-B13","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.berh.2023.101849","article-title":"Nailfold capillaroscopy","volume":"37","author":"Smith","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025121017320337200_keae669-B14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.180355","article-title":"Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: results of a multicenter international study","volume":"46","author":"Sebastiani","year":"2019","journal-title":"J Rheumatol"},{"key":"2025121017320337200_keae669-B15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/rheumatology\/keq430","article-title":"Association between nail-fold capillary findings and disease activity in dermatomyositis","volume":"50","author":"Mugii","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2025121017320337200_keae669-B16","first-page":"367","article-title":"Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies","volume":"42","author":"Torres-Ruiz","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2025121017320337200_keae669-B17","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/rheumatology\/keab772","article-title":"Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classfication: a systematic review and meta-analysis","volume":"61","author":"Umashankar","year":"2022","journal-title":"Rheumatology"},{"key":"2025121017320337200_keae669-B18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and SKL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"2025121017320337200_keae669-B19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.arbres.2024.03.028","article-title":"Diagnostic value of Krebs von den Lungen (SKL-6) for interstitial lung disease: a European prospective cohort","volume":"60","author":"Millan-Billi","year":"2024","journal-title":"Arch Bronconeumol"},{"key":"2025121017320337200_keae669-B20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43166-023-00206-9","article-title":"SKL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease","volume":"50","author":"Khalil","year":"2023","journal-title":"Egypt Rheumatol Rehabil"},{"key":"2025121017320337200_keae669-B21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025121017320337200_keae669-B22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"2025121017320337200_keae669-B23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/1756-185X.13559","article-title":"Overlap myositis, a distinct entity beyond primary inflammatory myositis: a retrospective analysis of a large cohort from the REMICAM registry","volume":"22","author":"Nu\u00f1o-Nu\u00f1o","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025121017320337200_keae669-B24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2025121017320337200_keae669-B25","first-page":"58","article-title":"Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies","volume-title":"Autoimmun Rev","author":"R\u00f6nnelid","year":"2009"},{"key":"2025121017320337200_keae669-B26","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025121017320337200_keae669-B27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3899\/jrheum.140276","article-title":"Association between nailfold capillaroscopy findings and pulmonary function tests in patients with systemic sclerosis","volume":"42","author":"Castellv\u00ed","year":"2015","journal-title":"J Rheumatol"},{"key":"2025121017320337200_keae669-B28","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","article-title":"Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study","volume":"71","author":"Smith","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025121017320337200_keae669-B29","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2025121017320337200_keae669-B30","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","article-title":"Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity","volume":"46","author":"Caramaschi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025121017320337200_keae669-B31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.2007.079756","article-title":"Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients","volume":"67","author":"Sulli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025121017320337200_keae669-B32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kev441","article-title":"An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases","volume":"55","author":"Smith","year":"2016","journal-title":"Rheumatology"},{"key":"2025121017320337200_keae669-B33","doi-asserted-by":"crossref","first-page":"102619","DOI":"10.1016\/j.autrev.2020.102619","article-title":"May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: are we looking for the holy grail? A systematic review","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025121017320337200_keae669-B34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13075-018-1775-9","article-title":"Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis","volume":"20","author":"Guill\u00e9n-Del-Castillo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025121017320337200_keae669-B35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/diagnostics10050253","article-title":"Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients","volume":"10","author":"Sambataro","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025121017320337200_keae669-B36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/rheumatology\/keq051","article-title":"Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy","volume":"49","author":"Mercer","year":"2010","journal-title":"Rheumatology"},{"key":"2025121017320337200_keae669-B37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/03009740701640209","article-title":"Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud\u2019s and Sj\u00f6gren\u2019s syndrome and poly\/dermatomyositis","volume":"37","author":"Szabo","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"2025121017320337200_keae669-B38","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s10067-019-04710-2","article-title":"Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy","volume":"38","author":"Soubrier","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025121017320337200_keae669-B39","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025121017320337200_keae669-B40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antib12010003","article-title":"Specific autoantibodies and microvascular damage progression assessed by nailfold videocapillaroscopy in systemic sclerosis: are there peculiar associations? An update","volume":"12","author":"Hysa","year":"2023","journal-title":"Antibodies (Basel)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae669\/61022358\/keae669.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI88\/61022358\/keae669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI88\/61022358\/keae669.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:32:13Z","timestamp":1765405933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/SI\/SI88\/7920412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":40,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae669","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2024,12,10]]}}}